New concepts for expressing forced expiratory volume in 1 s arising from survival analysis

Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 35; no. 4; pp. 873 - 882
Main Authors Miller, M. R, Pedersen, O. F
Format Journal Article
LanguageEnglish
Published Leeds Eur Respiratory Soc 01.04.2010
Maney
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised by powers of Ht and by a new sex-specific lower limit (FEV 1 quotient (FEV 1 Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV 1 Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV 1 PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV 1 ·Ht −3 was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV 1 Q and FEV 1 ·Ht −3 . These survival curves were accurately fitted (r 2 = 1.0) by both FEV 1 Q and FEV 1 ·Ht −3 values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV 1 Q, or, alternatively, as FEV 1 ·Ht −3 , since these indices best relate spirometric lung function to all-cause mortality and survival.
AbstractList Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival.Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival.
Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised by powers of Ht and by a new sex-specific lower limit (FEV 1 quotient (FEV 1 Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV 1 Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV 1 PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV 1 ·Ht −3 was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV 1 Q and FEV 1 ·Ht −3 . These survival curves were accurately fitted (r 2 = 1.0) by both FEV 1 Q and FEV 1 ·Ht −3 values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV 1 Q, or, alternatively, as FEV 1 ·Ht −3 , since these indices best relate spirometric lung function to all-cause mortality and survival.
Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival.
Author Pedersen, O. F
Miller, M. R
Author_xml – sequence: 1
  fullname: Miller, M. R
– sequence: 2
  fullname: Pedersen, O. F
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22555362$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19741033$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9v1DAQxS1URLeFD8AF-YI4pdgZ598RVVCQKrjAhYtlO5PWlWMvnmTLfvsm2t0eOHCwRvb83mie3wU7iykiY2-luJKyhY-iEyA7qK-EEGXViu4F20jougKEgDO2WfvFCpyzC6IHIWStQL5i57JrlBQAG_b7Oz5yl6LD7UR8SJnj321GIh_v1qvDfn3x2Uwp7_kuhXlE7iOXnLjJ_sDlNHKa887vTOAmmrAnT6_Zy8EEwjfHesl-ffn88_prcfvj5tv1p9vCKQFT4RB6gc6KoZe1rboSrFMt2M7axtZd39e1AxzUAK5VaCq7GALlcMCyhvVcsg-Huduc_sxIkx49OQzBREwz6QYAqqZRzUK-O5KzHbHX2-xHk_f69B0L8P4IGHImDNlE5-mZK8uqqqAuF645cC4nooyDdn4yk09xysYHLYVeA9KngPQpoEUp_1E-L_EfzXGre393_-gzahpNCIsJqTE_QKWVbheXT1UinvA
CitedBy_id crossref_primary_10_1183_13993003_01005_2018
crossref_primary_10_1183_09031936_00064710
crossref_primary_10_1183_09031936_00146012
crossref_primary_10_1183_13993003_00577_2017
crossref_primary_10_1183_13993003_01812_2017
crossref_primary_10_33790_jcnrc1100201
crossref_primary_10_1183_13993003_02025_2022
crossref_primary_10_1183_09031936_00008812
crossref_primary_10_1183_13993003_01622_2023
crossref_primary_10_1183_13993003_02225_2023
crossref_primary_10_1016_j_jamda_2016_08_012
crossref_primary_10_1183_09031936_00153113
crossref_primary_10_1016_j_mcna_2013_06_001
crossref_primary_10_1038_s41598_022_17261_5
crossref_primary_10_1016_j_rmed_2021_106441
crossref_primary_10_1080_17476348_2025_2458607
crossref_primary_10_4187_respcare_10757
crossref_primary_10_1164_rccm_202302_0310ST
crossref_primary_10_1093_gerona_glv201
crossref_primary_10_3310_pgfar09130
crossref_primary_10_1183_09031936_00187314
crossref_primary_10_1016_j_heliyon_2024_e31176
crossref_primary_10_1111_resp_13648
crossref_primary_10_1183_13993003_00033_2020
crossref_primary_10_1016_j_anai_2013_08_013
crossref_primary_10_1183_09031936_00086313
crossref_primary_10_1183_09031936_00086510
crossref_primary_10_1183_20734735_012113
crossref_primary_10_1016_j_jcf_2024_09_009
crossref_primary_10_1183_13993003_01499_2021
crossref_primary_10_1183_13993003_02046_2020
crossref_primary_10_1159_000447246
crossref_primary_10_1136_bmjresp_2020_000575
crossref_primary_10_1007_s40520_017_0792_x
crossref_primary_10_1016_j_arbres_2018_01_022
crossref_primary_10_1183_09031936_00104911
crossref_primary_10_1111_j_1532_5415_2011_03596_x
crossref_primary_10_1136_thoraxjnl_2017_210477
crossref_primary_10_7759_cureus_54176
crossref_primary_10_1111_j_1440_1843_2010_01850_x
crossref_primary_10_1007_s10654_012_9750_2
crossref_primary_10_1016_j_arbres_2025_02_011
crossref_primary_10_4187_respcare_07012
crossref_primary_10_1164_rccm_202011_4174LE
crossref_primary_10_1513_AnnalsATS_202405_515LE
crossref_primary_10_3389_fcvm_2023_1228807
crossref_primary_10_2147_COPD_S373834
crossref_primary_10_1183_13993003_01608_2022
crossref_primary_10_1097_ACO_0b013e32834e7ad2
crossref_primary_10_1016_j_resinv_2016_03_006
crossref_primary_10_2147_COPD_S492178
crossref_primary_10_1016_j_rmed_2015_11_005
crossref_primary_10_1016_j_rmed_2015_11_004
crossref_primary_10_1183_13993003_01711_2015
crossref_primary_10_1097_MCP_0000000000000943
crossref_primary_10_4082_kjfm_2018_39_2_85
crossref_primary_10_1177_1557988320922630
crossref_primary_10_1016_j_arbr_2018_01_028
crossref_primary_10_4187_respcare_01286
crossref_primary_10_1183_13993003_01326_2021
crossref_primary_10_1513_AnnalsATS_201802_104OC
crossref_primary_10_4187_respcare_05515
crossref_primary_10_3109_15412555_2011_558544
crossref_primary_10_1183_13993003_00354_2024
crossref_primary_10_1186_s12877_015_0013_4
crossref_primary_10_1055_s_0043_1766119
crossref_primary_10_1177_14799731241307252
Cites_doi 10.1152/ajplegacy.1948.154.3.405
10.1136/thx.34.4.569
10.1183/09031936.05.00034805
10.1016/S0195-668X(01)80001-4
10.1152/jappl.1996.81.4.1651
10.1164/ajrccm.159.4.9807121
10.1056/NEJM199810223391703
10.1164/ajrccm/140.2.379
10.1378/chest.108.3.656
10.1136/thx.47.1.14
10.1152/jappl.1999.87.3.920
10.1183/09041950.005s1693
10.1183/09031936.05.00035205
10.1136/thx.43.4.265
10.1136/thx.34.1.1
10.1016/j.rmed.2006.06.009
10.1111/j.1532-5415.2008.01969.x
10.1016/j.rmed.2008.09.016
10.1016/0895-4356(90)90070-6
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1183/09031936.00025809
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3003
EndPage 882
ExternalDocumentID 19741033
22555362
10_1183_09031936_00025809
erj35_4_873
Genre Journal Article
GroupedDBID -
02
1OC
2WC
53G
55
5GY
5RE
5VS
AALRV
AAPBV
ABFLS
ABOCM
ABSGY
ABYBQ
ACPRK
ADACO
ADBBV
ADDZX
AENEX
AFFNX
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CAG
CS3
DIK
E3Z
EBS
EJD
F5P
FH7
GX1
H13
INIJC
KQ8
L7B
O0-
OK1
P2P
PQEST
PQQKQ
R0Z
RHF
RHI
TER
WOQ
X7M
ZA5
ZE2
ZGI
---
.55
.GJ
18M
31~
3O-
8-1
AADJU
AAFWJ
AAYXX
AAZMJ
ABCQX
ABJNI
ABSQV
ACEMG
ACGFO
ACXQS
ADMOG
ADYFA
AFHIN
AFZJQ
AIZTS
AJAOE
BTFSW
CITATION
COF
F9R
J5H
LH4
LW6
TR2
W8F
ZXP
~02
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c403t-ce3d0ecb0fd16b5923bc483b9bb7b69dd66c3ef4f3c84ea5b19334cefe263e263
ISSN 0903-1936
1399-3003
IngestDate Fri Jul 11 12:25:18 EDT 2025
Thu Apr 03 07:07:12 EDT 2025
Wed Apr 02 07:20:09 EDT 2025
Thu Apr 24 23:08:02 EDT 2025
Tue Jul 01 05:42:38 EDT 2025
Tue Nov 10 19:19:16 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Spirometry
Lung function
Prognosis
Volume
respiratory function tests
Exploration
Cox's proportional hazards
Survival
Hazard
Pneumology
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c403t-ce3d0ecb0fd16b5923bc483b9bb7b69dd66c3ef4f3c84ea5b19334cefe263e263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://erj.ersjournals.com/content/erj/35/4/873.full.pdf
PMID 19741033
PQID 733357747
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_733357747
pubmed_primary_19741033
pascalfrancis_primary_22555362
crossref_citationtrail_10_1183_09031936_00025809
crossref_primary_10_1183_09031936_00025809
highwire_smallpub1_erj35_4_873
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-04-01
PublicationDateYYYYMMDD 2010-04-01
PublicationDate_xml – month: 04
  year: 2010
  text: 2010-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Leeds
PublicationPlace_xml – name: Leeds
– name: England
PublicationTitle The European respiratory journal
PublicationTitleAlternate Eur Respir J
PublicationYear 2010
Publisher Eur Respiratory Soc
Maney
Publisher_xml – name: Eur Respiratory Soc
– name: Maney
References 2024102020025204000_35.4.873.5
2024102020025204000_35.4.873.6
2024102020025204000_35.4.873.3
2024102020025204000_35.4.873.4
2024102020025204000_35.4.873.7
2024102020025204000_35.4.873.8
(2024102020025204000_35.4.873.25) 1948; 154
2024102020025204000_35.4.873.21
(2024102020025204000_35.4.873.9) 1989; 140
2024102020025204000_35.4.873.22
(2024102020025204000_35.4.873.16) 1999; 159
2024102020025204000_35.4.873.23
(2024102020025204000_35.4.873.19) 1993; 12
2024102020025204000_35.4.873.27
(2024102020025204000_35.4.873.24) 1996; 81
2024102020025204000_35.4.873.10
(2024102020025204000_35.4.873.26) 1999; 87
2024102020025204000_35.4.873.11
(2024102020025204000_35.4.873.20) 1985; 132
2024102020025204000_35.4.873.14
2024102020025204000_35.4.873.15
2024102020025204000_35.4.873.12
(2024102020025204000_35.4.873.17) 2007; 2
2024102020025204000_35.4.873.13
2024102020025204000_35.4.873.18
2024102020025204000_35.4.873.2
(2024102020025204000_35.4.873.1) 1846; 29
20930208 - Eur Respir J. 2010 Sep;36(3):693; author reply 694
References_xml – volume: 154
  start-page: 405
  year: 1948
  ident: 2024102020025204000_35.4.873.25
  publication-title: Am J Physiol
  doi: 10.1152/ajplegacy.1948.154.3.405
– ident: 2024102020025204000_35.4.873.5
  doi: 10.1136/thx.34.4.569
– ident: 2024102020025204000_35.4.873.14
  doi: 10.1183/09031936.05.00034805
– ident: 2024102020025204000_35.4.873.15
  doi: 10.1016/S0195-668X(01)80001-4
– volume: 81
  start-page: 1651
  year: 1996
  ident: 2024102020025204000_35.4.873.24
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1996.81.4.1651
– volume: 159
  start-page: 1267
  year: 1999
  ident: 2024102020025204000_35.4.873.16
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.159.4.9807121
– volume: 2
  start-page: 657
  year: 2007
  ident: 2024102020025204000_35.4.873.17
  publication-title: Int J COPD
– ident: 2024102020025204000_35.4.873.3
– ident: 2024102020025204000_35.4.873.21
  doi: 10.1056/NEJM199810223391703
– volume: 140
  start-page: 379
  year: 1989
  ident: 2024102020025204000_35.4.873.9
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/140.2.379
– ident: 2024102020025204000_35.4.873.22
  doi: 10.1378/chest.108.3.656
– ident: 2024102020025204000_35.4.873.23
  doi: 10.1136/thx.47.1.14
– ident: 2024102020025204000_35.4.873.10
– volume: 87
  start-page: 920
  year: 1999
  ident: 2024102020025204000_35.4.873.26
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1999.87.3.920
– volume: 29
  start-page: 137
  year: 1846
  ident: 2024102020025204000_35.4.873.1
  publication-title: Med Chir Trans
– ident: 2024102020025204000_35.4.873.7
  doi: 10.1183/09041950.005s1693
– ident: 2024102020025204000_35.4.873.8
  doi: 10.1183/09031936.05.00035205
– ident: 2024102020025204000_35.4.873.6
  doi: 10.1136/thx.43.4.265
– volume: 132
  start-page: 1034
  year: 1985
  ident: 2024102020025204000_35.4.873.20
  publication-title: Am Rev Respir Dis
– ident: 2024102020025204000_35.4.873.4
  doi: 10.1136/thx.34.1.1
– ident: 2024102020025204000_35.4.873.13
  doi: 10.1016/j.rmed.2006.06.009
– ident: 2024102020025204000_35.4.873.27
– ident: 2024102020025204000_35.4.873.2
– ident: 2024102020025204000_35.4.873.18
  doi: 10.1111/j.1532-5415.2008.01969.x
– ident: 2024102020025204000_35.4.873.11
  doi: 10.1016/j.rmed.2008.09.016
– ident: 2024102020025204000_35.4.873.12
  doi: 10.1016/0895-4356(90)90070-6
– volume: 12
  start-page: 669
  year: 1993
  ident: 2024102020025204000_35.4.873.19
  publication-title: J Heart Lung Transplant
– reference: 20930208 - Eur Respir J. 2010 Sep;36(3):693; author reply 694
SSID ssj0016431
Score 2.2684028
Snippet Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in...
SourceID proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 873
SubjectTerms Adult
Age Distribution
Aged
Biological and medical sciences
Body Height
Female
Forced Expiratory Volume
Humans
Lung Diseases - diagnosis
Lung Diseases - mortality
Male
Medical sciences
Middle Aged
Multivariate Analysis
Pneumology
Predictive Value of Tests
Proportional Hazards Models
Reference Values
Sex Distribution
Spirometry - standards
Spirometry - statistics & numerical data
Young Adult
Title New concepts for expressing forced expiratory volume in 1 s arising from survival analysis
URI http://erj.ersjournals.com/cgi/content/abstract/35/4/873
https://www.ncbi.nlm.nih.gov/pubmed/19741033
https://www.proquest.com/docview/733357747
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB60gvhS6n1bLfPgk0viJGdyexSxFGUVpYXiy5C5gbKmstktxV_vmUwmyVor1ocNy5AdZvN9OXPOnBshLxKJRrJKdIRXHXFb66hWKY9yZWqWl1aWnaG4-JAfn_J3Z9nZGKvaZZesZax-_jGv5H9QxTHE1WXJ3gDZYVIcwO-IL14RYbz-E8YuOFH5vMPW1-6-9HGtPjrSufZxJHjSvSByBxzJvJ275oPdfS6_pN2gxLjoygb4GiVTndUxaTi0X01c89M1bqUVLuL553gUui5W2ku3j_H8KJ4eNDgf-RCf0p8YujC2CvrK1V5eon6DMDOYClRff6QnDp9Ix9J3LQkbre86dFWGl9C5lFx-FThXEaplJavGDSs46X_bx4bows6uKUGEKUSY4ja5k6I14RpdvP80OptQKesaK4b_1zu_cYpXV1axrb6EktIuorZu8aWyvhvK9eZKp7ac7JHd3t6grz157pNbpnlA7i76iIqH5AtyiAYOUSQNHTlEPYfoyCHqnz392tCEtrTnEHUcooFDNHDoETk9envy5jjq-21EijNYR8qAZkZJZnWSywxVf6l4CbKSspB5pXWeKzCWW1AlN3Um8ckAV8aaNAf3eUx2mvPGPCW01tyyUtqUVZbnUNTaoqpUpAnOXmSVnhEWHqNQfTF61xNlKa4Fb0ZeDj_54Sux_O3mw4CNaL_XyyVikAiz-gaZ4AJ5iDdsITZMiftblqFWNyM0QChQ4jo3Wt2Y800rCgDI0GoqZuSJh3ZcD1rnCQPYv8laD8i98XV7RnbWq415jpruWh52PP0FV7Ci-Q
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+concepts+for+expressing+forced+expiratory+volume+in+1+s+arising+from+survival+analysis&rft.jtitle=The+European+respiratory+journal&rft.au=Miller%2C+M.+R.&rft.au=Pedersen%2C+O.+F.&rft.date=2010-04-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=35&rft.issue=4&rft.spage=873&rft.epage=882&rft_id=info:doi/10.1183%2F09031936.00025809&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_09031936_00025809
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon